Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Belumosudil for Chronic Graft-Versus-Host Disease: Analysis of Long-Term Results from the KD025-208 and ROCKstar Studies

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.04.020Source: DataRank Database

Belumosudil for Chronic Graft-Versus-Host Disease: Analysis of Long-Term Results from the KD025-208 and ROCKstar Studies is a research paper published in Transplantation and Cellular Therapy (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 2.33)OA: hybridTopics (51)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Steven Z. Pavletic ORCID,Bruce R. Blazar ORCID,Yu Yao ORCID,Ran Ji ORCID,Kathy Marshall

Live enrichment

PubMed:40318736 PMC:PMC12344584 OpenAlex:https://openalex.org/W4410000242

NHLBI NIH HHS

Grant: P01 HL158505

NIAID NIH HHS

Grant: R37 AI034495

Intramural NIH HHS

Grant: ZIA BC011743

Sanofi US

FWCI

2.33

Citation Percentile

0.9%

Citation Trend

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.jtct.2025.04.020

publisherhttps://doi.org/10.1016/j.jtct.2025.04.020

publisherhttps://api.elsevier.com/content/article/PII:S2666636725011595?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666636725011595?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40318736

Fields of Study

Hematopoietic Stem Cell TransplantationAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia TreatmentsAdolescentAdultAgedFemaleHumansMaleMiddle AgedYoung Adult1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineChronic DiseaseFollow-Up StudiesGraft vs Host DiseaseProtein Kinase Inhibitorsrho-Associated KinasesTreatment OutcomeAcetamides

MeSH Terms

AcetamidesAdolescentAdultAgedChronic DiseaseFemaleFollow-Up StudiesGraft vs Host DiseaseHumansMaleMiddle AgedTreatment OutcomeHematopoietic Stem Cell Transplantation1-(5-Isoquinolinesulfonyl)-2-MethylpiperazineProtein Kinase Inhibitorsrho-Associated KinasesYoung Adult

Keywords

Term (time)Graft-versus-host diseaseHost (biology)MedicineDiseaseBiologyInternal medicineGeneticsPhysicsBelumosudil Extended TreatmentBelumosudil Follow-upBelumosudil Long-term EfficacyBelumosudil Long-term SafetyChronic Gvhd TreatmentCgvhd Long-term Outcomes

Sustainable Development Goals

SDG 0: Zero hunger

Belumosudil for Chronic Graft-Versus-Host Disease: Analysis of Long-Term Results from the KD025-208 and ROCKstar Studies

FAIR Checklist

Authors (7)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)